US fund takes a liking to Ebos Group
US investment giant Fidelity has lifted its stake in NZX-listed medical and pharmaceutical products distributor Ebos Group [NZX: EBO] above 9%.
Boston-based Fidelity purchased 1.5 million Ebos shares between May 22 and July 10, increasing its holding from 8.06% to 9.06% according to a substantial security holder disclosure notice.
Ebos stock closed yesterday at $10.13. Fidelity acquired its shares at prices ranging from $9.32 to $10.20, according to its disclosure.